HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cameron Abrams Selected Research

1- (3- (2- hydroxyl- 3- piperidin- 1- yl- propoxy)- phenoxy)- 3- piperidin- 1- ylpropan- 2- ol

7/2022VE607 stabilizes SARS-CoV-2 Spike in the "RBD-up" conformation and inhibits viral entry.
2/2022VE607 Stabilizes SARS-CoV-2 Spike In the "RBD-up" Conformation and Inhibits Viral Entry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cameron Abrams Research Topics

Disease

5Infections
02/2022 - 10/2013
2COVID-19
07/2022 - 02/2022
2Virus Diseases (Viral Diseases)
01/2020 - 12/2019
1Vesicular Stomatitis
10/2013

Drug/Important Bio-Agent (IBA)

21- (3- (2- hydroxyl- 3- piperidin- 1- yl- propoxy)- phenoxy)- 3- piperidin- 1- ylpropan- 2- olIBA
07/2022 - 02/2022
2Glycoproteins (Glycoprotein)IBA
07/2022 - 02/2022
2AntibodiesIBA
01/2020 - 12/2019
2TriazolesIBA
01/2017 - 01/2015
2Peptides (Polypeptides)IBA
01/2017 - 01/2015
1Pharmaceutical PreparationsIBA
07/2022
1PF 68742IBA
11/2019
1env Gene ProductsIBA
01/2015
1Proteins (Proteins, Gene)FDA Link
01/2015
1Antiviral Agents (Antivirals)IBA
10/2013
1MetalsIBA
10/2013
1Recombinant ProteinsIBA
10/2013

Therapy/Procedure

2Therapeutics
07/2022 - 02/2022
2Immunotherapy
07/2022 - 02/2022